# Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

> **NCT02403531** · PHASE2 · COMPLETED · sponsor: **Mian XI** · enrollment: 110 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Cisplatin
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT02403531
- **Lead sponsor:** Mian XI
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2017-09-06
- **Final completion:** 2020-05-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02403531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02403531, "Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02403531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*